The numbers don't lie, but they can be selectively presented. On August 19, a joint letter from the Hyperliquid Policy Center (HPC) and the pseudonymous entity trade[XYZ] landed on the SEC's desk, proposing a new asset class: Initial Pre-IPO Perpetuals (IPOPs). The letter claims that over five completed IPOP markets, the average IPO opening price was within 1.2% of the final IPOP settlement price, while the IPO issuance price was on average 18.5% below the IPOP price the day before listing. That's a compelling narrative for price discovery efficiency. But as a data detective who has spent years reverse-engineering smart contracts and modeling liquidity risks, I see the cracks in the foundation. The data is self-reported, the settlement mechanism is opaque, and the regulatory framework is a minefield. Let me walk you through the forensic analysis.
Context: The Players and the Product Hyperliquid is a high-throughput perpetual swap DEX built on its own order book and on-chain matching engine. HPC is presented as a policy advocacy arm, and trade[XYZ] is likely a market maker or liquidity provider—the letter does not disclose its real identity. IPOPs are synthetic perpetual contracts that use a company's IPO as a termination event: traders can go long or short the future stock price, but the contract confers no equity, allocation rights, or voting power. The product has been live for five markets, including a well-known tech IPO, and the letter uses these as proof of concept. The pitch to the SEC is that IPOPs improve price discovery for IPOs, reduce the well-documented underpricing phenomenon, and provide a continuous synthetic market for pre-IPO price discovery. The letter also explicitly asks for regulatory clarity on classification, disclosure, eligibility, market integrity, and investor accessibility. On the surface, it's a proactive compliance move. Underneath, it's a high-stakes bet on regulatory arbitrage.
Core: The On-Chain Evidence Chain—and Its Missing Links Let's start with the data. The five IPOP markets each ran from the announcement of an IPO to the first day of trading. The letter claims that the IPOP settlement price (the price at which the contract expires) accurately reflected the actual opening price, with an average deviation of 1.2%. The more striking number is the 18.5% discount of the IPO issuance price relative to the IPOP price the day before listing. This is framed as evidence that IPOs are systematically underpriced, and that IPOPs provide a more accurate market price. But as a quantitative analyst who built impermanent loss models during DeFi Summer, I know that sample size matters. Five markets is not statistically significant. The variance is high: the discounts ranged from 10.8% to 38.4%. That's a range, not a consistent signal. Furthermore, the data is provided by the same entities that operate the market and have a financial interest in its adoption. When code speaks, we listen for the discrepancies. Here, the code is the IPOP contract, and the discrepancies are in the settlement mechanism.
The settlement price source is not disclosed. In a traditional perpetual, the price is derived from an oracle referencing a spot market. For IPOPs, the contract terminates at the IPO opening price. But who determines that price? Is it the official exchange opening print, the first trade, or a volume-weighted average? The letter does not specify. This is a critical technical detail. In my 2022 post-mortem of the Terra/Luna collapse, I traced the exact moment when the oracle feed lag caused a cascade of liquidations. A similar opacity here could lead to manipulation. If the settlement price is derived from a single source (e.g., a specific exchange feed), a malicious actor could execute a spoofing attack on that exchange just before the IPO to skew the IPOP settlement. The lack of a decentralized oracle or a time-weighted average protocol is a red flag.
The liquidity assumption is untested. The five markets had limited volume compared to the total size of the IPOs. The letter does not provide order book depth, slippage data, or the maximum open interest. In my experience modeling NFT floor price bot activity for BAYC, I found that 40% of apparent demand was from 15 high-frequency wallets. The IPOP market could be similarly thin. If the SEC approves IPOPs for broader use, the liquidity on Hyperliquid must scale exponentially. Currently, the platform's total value locked (TVL) is not publicly audited, and the order book is central to Hyperliquid's architecture. The sequencer is effectively a single point of failure. Layer2 sequencers are basically centralized nodes; decentralized sequencing has been a PowerPoint for two years. The same applies to Hyperliquid's matching engine. The IPOP market's integrity depends on the operator's good faith, not on cryptographic guarantees.
The regulatory classification is a minefield. Under the Howey test, the IPOP contract itself is likely not a security—it's a derivative. But the underlying asset (the IPO stock) is a security. The SEC has jurisdiction over security-based swaps. The letter asks for a clear classification, but the mere act of asking reveals the uncertainty. The IPOP could be a "swap" under the Dodd-Frank Act, requiring registration with the SEC and CFTC. The letter attempts to preempt this by arguing that IPOPs are not "security-based swaps" because they do not reference a specific security (the IPO is a future event). This is a clever legal argument, but it's untested. When code speaks, we listen for the discrepancies. The code of the IPOP contract references the IPO event, which is inherently tied to a security. The SEC may view this as a de facto security-based swap.
The risk of insider trading is acute. The letter acknowledges this by asking about market integrity and investor accessibility. But it provides no concrete safeguards. The IPOP market runs from the IPO announcement to the listing, a period of intense information asymmetry. Underwriters, company insiders, and early investors have material non-public information about the IPO price range. If they can trade IPOPs, they can lock in profits or hedge risk before the public. The letter does not address whether KYC or accredited investor requirements are in place. In my 2017 ICO audit experience, I found that projects with similar gaps in disclosure often had backdoor access for insiders. The IPOP model is a prime candidate for regulatory enforcement action.
Contrarian: The Discount Is Not a Feature, It's a Bug The letter's central claim—that IPOPs reveal IPO underpricing—is actually a double-edged sword. IPO underpricing is a well-documented phenomenon where issuers intentionally set the offer price below market value to ensure a successful raise. The 18.5% discount is consistent with academic literature. But the IPOP price the day before the IPO is not a "true" price; it's a synthetic price generated by a small group of traders on a single platform. Correlation is not causation in DeFi. The discount could simply reflect the fact that IPOP traders are speculators who price in a risk premium for the uncertainty of the IPO opening. The SEC could argue that IPOPs are not discovering the true price but rather creating a volatile, speculative market that distorts the actual IPO process. The letter's data can be interpreted as evidence that IPOPs are a source of misinformation, not information.
Furthermore, the proposal's success would create a structural conflict of interest. If Hyperliquid becomes the dominant venue for pre-IPO price discovery, its market maker (trade[XYZ]) has an incentive to manipulate the price to benefit its own trading positions. The letter does not address this. The absence of a decentralized oracle and audited settlement mechanism makes the system fragile. In my 2024 Bitcoin ETF flow study, I found that institutional accumulation decoupled from short-term price movements only when custody data was transparent and verifiable. IPOPs lack that transparency.
Takeaway: The Next-Week Signal The immediate market reaction to this letter will be muted. HYPE price is driven by trading volume and narrative, not by regulatory proposals. But the real signal is the SEC's response. If the SEC issues a no-action letter or proposes a regulatory sandbox, the IPOP concept could attract institutional interest. If the SEC remains silent, the product continues in a gray area. If the SEC files a cease-and-desist, Hyperliquid's expansion plans are set back. The data to watch is not the price of HYPE, but the on-chain activity on Hyperliquid: look for new IPOP markets, the size of open interest, and any wallet clustering that suggests insider trading. The next week will tell us whether this is a genuine innovation or a regulatory trap. Audit the code, ignore the narrative. The code of IPOPs is still missing too many critical lines.